-
1
-
-
0004047129
-
-
2nd ed. Churchill Livingstone, Edinburgh, TX
-
Therapeutic Drugs, 2nd ed. C. Dollery, eds. Churchill Livingstone, Edinburgh, TX, 1999.
-
(1999)
Therapeutic Drugs
-
-
Dollery, C.1
-
2
-
-
38949098548
-
-
The Stationary Office, London, UK
-
British Pharmacopoeia. The Stationary Office, London, UK, 2007.
-
(2007)
British Pharmacopoeia
-
-
-
3
-
-
0034893513
-
Adherence assessments and the use of depot antipsychotics in patients with schizophrenia
-
M. Valenstein, L.A. Copeland, R. Owen, F.C. Blow, S. Visnic. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J. Clin. Psychiatry. 62: 545-51 (2001). (Pubitemid 32703095)
-
(2001)
Journal of Clinical Psychiatry
, vol.62
, Issue.7
, pp. 545-551
-
-
Valenstein, M.1
Copeland, L.A.2
Owen, R.3
Blow, F.C.4
Visnic, S.5
-
4
-
-
0025047522
-
Newmethods of drug delivery
-
R. Langer. Newmethods of drug delivery. Science. 249: 1527-1533 (1990).
-
(1990)
Science.
, vol.249
, pp. 1527-1533
-
-
Langer, R.1
-
5
-
-
33646538099
-
Biosensing and drug delivery by polypyrrole
-
DOI 10.1016/j.aca.2005.10.011, PII S0003267005017046, Molecular Electronics and Analytical Chemistry
-
S. Geetha, C.R. Rao, M. Vijayan, D. Trivedi. Biosensing and drug delivery by polypyrrole. Analytica Chimica Acta. 568: 119-125 (2006). (Pubitemid 43729732)
-
(2006)
Analytica Chimica Acta
, vol.568
, Issue.1-2
, pp. 119-125
-
-
Geetha, S.1
Rao, C.R.K.2
Vijayan, M.3
Trivedi, D.C.4
-
6
-
-
34249283702
-
Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole
-
DOI 10.1016/j.jconrel.2006.09.004, PII S0168365906004561
-
B.C. Thompson, S.E. Moulton, J. Ding, R. Richardson, A. Cameron, S. O'Leary, et al. Optimising the incorporation and release of a neu- rotrophic factor using conducting polypyrrole. Journal of Controlled Release. 116: 285-94 (2006). (Pubitemid 44827404)
-
(2006)
Journal of Controlled Release
, vol.116
, Issue.3
, pp. 285-294
-
-
Thompson, B.C.1
Moulton, S.E.2
Ding, J.3
Richardson, R.4
Cameron, A.5
O'Leary, S.6
Wallace, G.G.7
Clark, G.M.8
-
7
-
-
33846785326
-
The role of degradant profiling in active pharmaceutical ingredients and drug products
-
DOI 10.1016/j.addr.2006.10.006, PII S0169409X06002730
-
K.M. Alsante, A. Ando, R. Brown, J. Ensing, T.D. Hatajik, W. Kong, et al. The role of degradant profiling in active pharmaceutical ingredients and drug products. Advanced Drug Delivery Reviews. 59: 29-37 (2007). (Pubitemid 46204933)
-
(2007)
Advanced Drug Delivery Reviews
, vol.59
, Issue.1
, pp. 29-37
-
-
Alsante, K.M.1
Ando, A.2
Brown, R.3
Ensing, J.4
Hatajik, T.D.5
Kong, W.6
Tsuda, Y.7
-
8
-
-
0036178655
-
Available guidance and best practices for conducting forced degradation studies
-
D.W. Reynolds, K.L. Facchine, J.F. Mullaney, K.M. Alsante, T.D. Hatajik, and M.G. Motto. Available guidance and best practices for conducting forced degradation studies. Pharmaceutical Technology. 26: 48-56 (2002). (Pubitemid 34160670)
-
(2002)
Pharmaceutical Technology
, vol.26
, Issue.2
, pp. 48-56
-
-
Reynolds, D.W.1
Facchine, K.L.2
Mullaney, J.F.3
Alsante, K.M.4
Hatajik, T.D.5
Motto, M.G.6
-
10
-
-
0034666523
-
Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection
-
DOI 10.1016/S0378-4347(00)00323-6, PII S0378434700003236
-
A. Avenoso, G. Facciola,M. Salemi, and E. Spina. Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reverse-phase liquid chromatography with ultraviolet detection. J. Chromatography B. 746: 173-181 (2000). (Pubitemid 30657933)
-
(2000)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.746
, Issue.2
, pp. 173-181
-
-
Avenoso, A.1
Facciola, G.2
Salemi, M.3
Spina, E.4
-
11
-
-
0032985205
-
Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: Reappraisal of interindividual variability factors
-
DOI 10.1097/00007691-199902000-00017
-
A.E. Balant-Gorgia, M. Gex-Fabry, C. Genet, and L.P. Balant. Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors. Therapeutic Drug Monitoring. 21: 105-115 (1999). (Pubitemid 29077463)
-
(1999)
Therapeutic Drug Monitoring
, vol.21
, Issue.1
, pp. 105-115
-
-
Balant-Gorgia, A.E.1
Gex-Fabry, M.2
Genet, C.3
Balant, L.P.4
-
12
-
-
11144256427
-
High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets
-
DOI 10.1016/j.jpba.2004.07.014, PII S0731708504003176
-
Z.A. El-Sherif, B. El-Zeany, and O.M. El-Houssini. High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets. J. Pharmaceutical and Biomedical Analysis. 36: 975-981 (2005). (Pubitemid 40037817)
-
(2005)
Journal of Pharmaceutical and Biomedical Analysis
, vol.36
, Issue.5
, pp. 975-981
-
-
El-Sherif, Z.A.1
El-Zeany, B.2
El-Houssini, O.M.3
-
13
-
-
0027271954
-
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection
-
DOI 10.1016/0378-4347(93)80327-Z
-
J. LeMoing, S. Edouard, and J. Levron.Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatography. 614: 333-9 (1993). (Pubitemid 23142091)
-
(1993)
Journal of Chromatography - Biomedical Applications
, vol.614
, Issue.2
, pp. 333-339
-
-
Le Moing, J.P.1
Edouard, S.2
Levron, J.C.3
-
14
-
-
0032969946
-
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: Application to therapeutic drug monitoring in Japanese patients with schizophrenia
-
DOI 10.1016/S0731-7085(98)00261-1, PII S0731708598002611
-
T. Nagasaki, T. Ohkubo, K. Sugawara, N. Yasui, H. Furukori, and S. Kaneko. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drugmonitoring in Japanese patientswith schizophrenia. J. Pharmaceutical and Biomedical Analysis. 19: 595-601 (1999). (Pubitemid 29073517)
-
(1999)
Journal of Pharmaceutical and Biomedical Analysis
, vol.19
, Issue.3-4
, pp. 595-601
-
-
Nagasaki, T.1
Ohkubo, T.2
Sugawara, K.3
Yasui, N.4
Furukori, H.5
Kaneko, S.6
-
15
-
-
15944387339
-
HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes
-
DOI 10.1002/jssc.200401939
-
M.A. Raggi, F. Bugamelli, C. Sabbioni,M.A. Saracino, and C. Pertio. HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes. J. Separation Science. 28: 245-50 (2005). (Pubitemid 40439604)
-
(2005)
Journal of Separation Science
, vol.28
, Issue.3
, pp. 245-250
-
-
Raggi, M.A.1
Bugamelli, F.2
Sabbioni, C.3
Saracino, M.A.4
Petio, C.5
-
16
-
-
4444220443
-
Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms
-
DOI 10.1016/j.jpba.2004.05.022, PII S0731708504002511
-
R.S. Tomar, T.J. Joseph, A.S.R.Murthy, D.V. Yadav, G. Subbaiah, and K.K. Reddy. Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms. J. Pharmaceutical and Biomedical Analysis. 36: 231-5 (2004). (Pubitemid 39209430)
-
(2004)
Journal of Pharmaceutical and Biomedical Analysis
, vol.36
, Issue.1
, pp. 231-235
-
-
Tomar, R.S.1
Joseph, T.J.2
Murthy, A.S.R.3
Yadav, D.V.4
Subbaiah, G.5
Krishna Reddy, K.V.S.R.6
-
17
-
-
0037097780
-
Development of validated stability-indicating assay methods - Critical review
-
DOI 10.1016/S0731-7085(02)00047-X, PII S073170850200047X
-
M. Bakshi and S. Singh. Development of validated stability-indicating assay methods - critical review. J. Pharmaceutical and Biomedical Analysis. 28: 1011-40 (2002). (Pubitemid 34607392)
-
(2002)
Journal of Pharmaceutical and Biomedical Analysis
, vol.28
, Issue.6
, pp. 1011-1040
-
-
Bakshi, M.1
Singh, S.2
-
19
-
-
76549115011
-
Development of a controlled release system for risperidone using polypyrrole: Mechanistic studies
-
D. Svirskis, B.E. Wright, J. Travas-Sejdic, A. Rodgers, and S. Garg. Development of a controlled release system for risperidone using polypyrrole: Mechanistic studies. Electroanalysis. 22: 439-44 (2010).
-
(2010)
Electroanalysis.
, vol.22
, pp. 439-444
-
-
Svirskis, D.1
Wright, B.E.2
Travas-Sejdic, J.3
Rodgers, A.4
Garg, S.5
-
21
-
-
78049427728
-
Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system
-
D. Svirskis, B.E. Wright, J. Travas-Sejdic, A. Rodgers, and S. Garg. Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system. Sensors and Actuators B. 151: 97-102 (2010).
-
(2010)
Sensors and Actuators B.
, vol.151
, pp. 97-102
-
-
Svirskis, D.1
Wright, B.E.2
Travas-Sejdic, J.3
Rodgers, A.4
Garg, S.5
|